ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 935,03
-1,52%
Dow Jones
38 441,54
-1,06%
DAX
18 473,29
-1,13%
Brent Oil
83,445
0,08%
Bitcoin
67 585,40
0,00%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Ainos Inc (AIMD)

  7. Ainos Inc (AIMD) Actualités

AIMD

Ainos (AIMD)

Ainos Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:AIMD
DateHeureSourceTitreSymboleSociété
11/03/202421h10Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:AIMDAinos Inc
08/03/202422h20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AIMDAinos Inc
08/03/202422h10Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:AIMDAinos Inc
20/02/202422h11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AIMDAinos Inc
15/02/202420h02Edgar (US Regulatory)Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]NASDAQ:AIMDAinos Inc
08/02/202414h35GlobeNewswire Inc.Small-Cap Growth Virtual Investor Conference Presentations Now Available for Online ViewingNASDAQ:AIMDAinos Inc
06/02/202415h51GlobeNewswire Inc.Small-Cap Growth Virtual Investor Conference Agenda Announced for February 7th, 2024NASDAQ:AIMDAinos Inc
01/02/202414h35GlobeNewswire Inc.Ainos, Inc. to Present at Small-Cap Growth Virtual Investor Conference February 7thNASDAQ:AIMDAinos Inc
19/12/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:AIMDAinos Inc
15/12/202323h22Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:AIMDAinos Inc
08/12/202323h22Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:AIMDAinos Inc
09/11/202322h28Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AIMDAinos Inc
27/10/202322h18Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AIMDAinos Inc
27/10/202322h18Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:AIMDAinos Inc
27/10/202322h12Edgar (US Regulatory)Form DEF 14C - Other definitive information statementsNASDAQ:AIMDAinos Inc
16/10/202323h30Edgar (US Regulatory)Form PRE 14C - Other preliminary information statementsNASDAQ:AIMDAinos Inc
14/06/202322h07Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:AIMDAinos Inc
02/06/202322h06Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:AIMDAinos Inc
18/05/202323h13Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AIMDAinos Inc
12/05/202322h34Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AIMDAinos Inc
26/04/202322h36Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AIMDAinos Inc
03/04/202312h17Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:AIMDAinos Inc
03/04/202312h04Edgar (US Regulatory)Annual Report (10-k)NASDAQ:AIMDAinos Inc
08/03/202312h01Edgar (US Regulatory)Proxy Statement - Other Information (preliminary) (pre 14c)NASDAQ:AIMDAinos Inc
21/11/202211h30PR Newswire (US)Ainos Publishes Preclinical Data Demonstrating its VELDONA Formulation's Potential as Treatment Candidates for the Most Common Medical Conditions for Companion AnimalsNASDAQ:AIMDAinos Inc
07/11/202213h30PR Newswire (US)Ainos Reports Unaudited Third Quarter 2022 Financial ResultsNASDAQ:AIMDAinos Inc
03/11/202212h00PR Newswire (US)Five New Drug Candidates Show Promise as Ainos Pursues Licensing Partners of its Low-dose Oral Interferon FormulationNASDAQ:AIMDAinos Inc
02/09/202212h05Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:AIMDAinos Inc
10/08/202222h32Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)NASDAQ:AIMDAinos Inc
 Showing the most relevant articles for your search:NASDAQ:AIMD

Dernières Valeurs Consultées

AMEX
HMV
LSE
60ZO
Investec Bnk 25
USOTC
AFOVF
Australian Foundation In... (PK)
BIT
I08994
Intesa Sanpaolo
COIN
KERMITUSD
Kermit
BOV
D2KN34R
DraftKings
TSXV
AQUA
Aquarius AI
ASX
LOMNF
Lucapa Diamond
ASX
OZLKOE
BIT
F11815
Vontobel Financial Produ...
AQSE
XACTOMX.GB
XACT Fonder AB
BIT
P1PM25
BNP Paribas Issuance
USOTC
EIZOF
EIZO Nanao (PK)
LSE
BM50
Sutton E.s.bds
TSXV
SGU
Signature Resources
NYSE
LZM
Lifezone Metals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés